Stay updated with breaking news from Technion Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company partners with Israel Institute of Technology on research and development of AI-driven methods for atrial fibrillation procedures
The (Forgotten) Deal Altria Group bought a 45 percent stake in leading cannabinoid company Cronos Group for about $1.8 billion. Altria also has a warrant that would allow it to increase its stake in Cronos to about 55 percent at a price of $19 per share. It allows Cronos the flexibility to take investments from other companies such as, for example, a big food company. “The proceeds from Altria’s investment will enable us to more quickly expand our global infrastructure and distribution footprint, while also increasing investments in R&D and brands that resonate with our consumer,” Cr...
Image by Viacheslav Iakobchuk - Adobe Stock Illumina has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the United States and the United Kingdom. Unlocking the power of the human genome is a feat that no one organization can fully accomplish on its own. That's why, back in 2014, Illumina created the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Now in its sixth year, the Illumina Accelerator has just selected nine new genomics companies to jo...